Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia

MLA

Nirmani Yasara, et al. “Synergistic Silencing of α-Globin and Induction of γ-Globin by Histone Deacetylase Inhibitor, Vorinostat as a Potential Therapy for β-Thalassaemia.” Scientific Reports, vol. 9, Aug. 2019. EBSCOhost, https://doi.org/10.1038/s41598-019-48204-2.

APA

Nirmani Yasara, Stephen S. Taylor, Chris Fisher, Sachith Mettananda, Richard J. Gibbons, & Doug Higgs. (2019). Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia. Scientific Reports, 9. https://doi.org/10.1038/s41598-019-48204-2

Chicago

Nirmani Yasara, Stephen S. Taylor, Chris Fisher, Sachith Mettananda, Richard J. Gibbons, and Doug Higgs. 2019. “Synergistic Silencing of α-Globin and Induction of γ-Globin by Histone Deacetylase Inhibitor, Vorinostat as a Potential Therapy for β-Thalassaemia.” Scientific Reports 9 (August). doi:10.1038/s41598-019-48204-2.